NLS Pharma Business

The expanded agreement extends the existing collaboration between the companies established in November 2025, under which Karo Healthcare is responsible for marketing, distribution, and sales across 19 European markets with a combined population of approximately 500 million people.

Saphnelo (anifrolumab) has been approved in the US for self-administration as a once-weekly autoinjector, the Saphnelo Pen, for the treatment of adult patients with systemic lupus erythematosus (SLE) on top of standard therapy.

Nanologica has received an order of appx. SEK 2 million for the company’s silica-based purification media NLAB Saga.

Immedica has announced that the Kuwait Ministry of Health (MOH) has granted Marketing Authorization (MA) approval for Ztalmy (ganaxolone) for the treatment of seizures associated with CDKL5 deficiency disorder (CDD) in Kuwait.

Diamyd Medical have announced the completion of a pre-specified interim efficacy analysis on C-peptide in the ongoing Phase 3 DIAGNODE-3 trial evaluating retogatein (rhGAD65) in individuals with recent-onset Stage 3 type 1 diabetes carrying the HLA DR3-DQ2 haplotype. The interim analysis that included 174 out of 321 study participants did not demonstrate statistical significance on […]

Mendus has entered into an agreement with the Olivia Newton-John Cancer Research Institute (ONJCRI), an Australian cancer research institute, to support the DIVA trial with the company’s lead product vididencel in acute myeloid leukemia (AML).